Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) is expected to earn ($2.37) per share ...

Retrieved on: 2022-11-12 18:24:52

Tags for this article:

Click the tags to see associated articles and topics

Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) is expected to earn ($2.37) per share .... View article details on hiswai:

Excerpt

The biotechnology company will earn $2.37 a share this year, down from $2.34 last year, predicts HC Wainwright analyst D. Tsao.

Article found on: beststocks.com